We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Thromboelastography Applied in Diagnosing Normal and Complicated Pregnancies

By LabMedica International staff writers
Posted on 04 May 2022

During pregnancy, the coagulation system in women undergoes considerable changes to prevent bleeding. More...

If the coagulation system in pregnant women is not functioning optimally, incidents such as bleeding and miscarriage are prone to occur; if the coagulation system in pregnant women is hyperfunctional, the risk of venous thrombosis is high.

At present, many indicators such as activated partial prothrombin time and prothrombin time are used to detect blood coagulation function in the body. Thromboelastography (TEG), as a currently accessible laboratory test, can reflect the dynamic changes in the coagulation process and has high application value in evaluating platelet function.

Hematologists at the Affiliated Hospital of Hubei Polytechnic University (Huangshi, China) collected samples for 156 pregnant women with normal pregnancy (NP) and 58 women with threatened abortion (TA), 13 with missed abortion (MAb), 25 with embryo arrest (EA), four with fetal death (FD), six with a history of abnormal pregnancy (HAP), and seven with antiphospholipid antibody syndrome (AA).

TEG was performed using a BVCA-I thromboelastometer. The parameters R, K, α-angle, MA, LY-30, G, and coagulation index (CI) were analyzed. Partial correlation analysis was used to analyze correlation between groups of data. LSD-t test and Dunnett's T3 test were used to analyze continuous variables. Ordinal categorical variables were compared using ordinal logistic regression analysis and estimate odds ratio of risk factors. A receiver operating characteristic (ROC) curve was constructed to detect the ability of TEG to recognize various parameters, and areas under the curve were compared using Delong's test for diagnosing pregnancy-related diseases.

The scientists reported that there was no correlation between the data of NP and TA, and NP and FD groups; MAb had a negative effect on the MA parameter in TEG; EA had a negative effect on the MA and G parameters; HAP had a negative effect on the CI parameter and a positive effect on the R parameter; AA had a negative effect on the CI parameter. The team found that TEG parameters were different between some patient groups and control groups. For example, the CI value of the TA group was decreased, and the ratio of the angle value lower than the upper limit of the normal reference value was higher than that of the NP group, indicating that the coagulation function is low, and there could be a problem of inadequate fibrin levels or function.

The authors concluded that TEG has a good clinical significance in the diagnosis of TA, MAb, EA, AA, and HAP. The study was published on April 24, 2022 in the Journal of Clinical Laboratory Analysis.

Related Links:
Affiliated Hospital of Hubei Polytechnic University


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Microscope
dIFine
New
Silver Member
Quality Control Material
Multichem ID-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.